OR WAIT null SECS
© 2022 MJH Life Sciences and Contemporary Pediatrics. All rights reserved.
© 2022 MJH Life Sciences™ and Contemporary Pediatrics. All rights reserved.
September 30, 2022
A review examined the ways in which costs can be reduced for patients with varying types of atopic dermatitis.
September 26, 2022
A previously healthy 11-year-old boy presents with purpuric macules and papules symmetrically distributed on his buttocks and upper and lower extremities. What’s the diagnosis?
August 17, 2022
A 4-week-old boy presents with creamy white patches on his lips, right and left buccal mucosa, palate, and tongue.
August 15, 2022
Investigators have found that there are limited options for treating pediatric psoriasis.
August 01, 2022
Janssen Pharmaceutical Companies of Johnson & Johnson announced the approval of ustekinumab as a new treatment option for patients aged 6 years or older with active psoriatic arthritis.
July 29, 2022
Arcutis Biotherapeutics’ roflumilast cream will provide relief to patients aged 12 years or older diagnosed with plaque psoriasis.
July 27, 2022
A healthy 14-year old boy was evaluated for an intensely pruritic shin rash that developed 2 weeks prior and had been treated with oral antibiotics for 10 days.
July 22, 2022
Stephen Stripling, MD, FAAP, discusses results published in JAMA Dermatology about the efficacy and safety of berdazimer gel 10.3% for the treatment of molluscum contagiosum.
July 19, 2022
Opzelura (ruxolitinib) cream is the first and only FDA-approved treatment for adult and pediatric patients 12 years of age or older with vitiligo.
July 13, 2022
A better understanding of this atopic diathesis and the atopic march often seen in pediatric patients is necessary to optimally treat and manage the patient population, ideally in a multidisciplinary setting.